Alixia

Targeting the Tumor Ecosystem to address cancer drug resistance.

Health & FitnessYC Winter 2022tracked since Sep 25, 2026
WatchVisit site ↗
Monthly revenue–Not shared yet
Rank–Unranked
Last 30 days–Growth in MRR
Revenue per founder–– founders

About Alixia

Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.

Discover more startups

Browse the board →